#Bridge_to_Life hashtag - Bluesky

@newsen.bsky.social

1 week ago

Revolutionary VitaSmart™ HOPE System Launched at Duke University Hospital After FDA Clearance Duke University Hospital has officially implemented the VitaSmart™ Hypothermic Oxygenated Perfusion System, following its FDA clearance, marking a significant advancement in organ transplantation techniques.

Revolutionary VitaSmart™ HOPE System Launched at Duke University Hospital After FDA Clearance #USA #VitaSmart #Bridge_to_Life #Duke_University #Duke_University,_North_Carolina

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bridge to Life Secures FDA Approval for Innovative VitaSmart Hypothermic Oxygenated Perfusion System Bridge to Life has received FDA's De Novo approval for its VitaSmart hypothermic oxygenated perfusion system, revolutionizing liver transplantation.

Bridge to Life Secures FDA Approval for Innovative VitaSmart Hypothermic Oxygenated Perfusion System #USA #FDA_Approval #Duluth #VitaSmart #Bridge_to_Life

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

FDA Grants De-Novo Clearance for VitaSmart HOPE System for Liver Transplants Bridge to Life secures FDA approval for the VitaSmart HOPE system, marking a milestone in liver transplant preservation technology with broader clinical applicability.

FDA Grants De-Novo Clearance for VitaSmart HOPE System for Liver Transplants #United_States #Duluth #VitaSmart #Bridge_to_Life #Liver_Transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bridge to Life's VitaSmart System Gains FDA Approval for Liver Transplant Preservation Bridge to Life™ Ltd. has achieved a key milestone with FDA De Novo clearance for its VitaSmart™ system, transforming liver transplant preservation practices in the U.S.

Bridge to Life's VitaSmart System Gains FDA Approval for Liver Transplant Preservation #USA #FDA_Approval #VitaSmart #Bridge_to_Life #Duluth,_Georgia

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bridge to Life™ Achieves FDA De Novo Authorization for the VitaSmart™ HOPE System, Revolutionizing Organ Preservation Bridge to Life™ has received FDA De Novo approval for the VitaSmart™ HOPE system, the first of its kind for hypothermic perfusion of donor livers in the U.S.

Bridge to Life™ Achieves FDA De Novo Authorization for the VitaSmart™ HOPE System, Revolutionizing Organ Preservation #USA #Duluth #Bridge_to_Life #VitaSmart™ #HOPE_System

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bridge to Life™ Receives De Novo FDA Authorization for HOPE VitaSmart™ System Bridge to Life™ Ltd. has achieved FDA De Novo authorization for its HOPE VitaSmart™ system, marking a significant advancement in organ preservation technology in the U.S.

Bridge to Life™ Receives De Novo FDA Authorization for HOPE VitaSmart™ System #USA #FDA_Approval #Duluth #Bridge_to_Life #HOPE_VitaSmart

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

Bridge to Life Achieves FDA Clearance for Enhanced Organ Preservation Solutions Bridge to Life, Ltd. has received FDA 510(k) clearance for its innovative organ preservation solutions, expanding access for abdominal organs and enhancing transplantation technology.

Bridge to Life Achieves FDA Clearance for Enhanced Organ Preservation Solutions #United_States #Duluth #Bridge_to_Life #FDA_510(k) #Belzer_UW

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Bridge to Life Welcomes David Castiglioni as Chief Commercial Officer to Drive Global Operations Bridge to Life has appointed David Castiglioni as Chief Commercial Officer. He will lead global operations and prepare for the U.S. launch of VitaSmart™.

Bridge to Life Welcomes David Castiglioni as Chief Commercial Officer to Drive Global Operations #USA #Chicago #Bridge_to_Life #VitaSmart™ #Castiglioni

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Bridge to Life Welcomes Brian Lenz as New CFO to Drive Growth and Innovation Bridge to Life Ltd has appointed Brian Lenz, an experienced finance executive, as Chief Financial Officer to enhance growth strategies, particularly for the VitaSmart™ product line.

Bridge to Life Welcomes Brian Lenz as New CFO to Drive Growth and Innovation #United_States #Chicago #VitaSmart #Bridge_to_Life #Brian_Lenz

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Significant Clinical and Economic Benefits of HOPE in Liver Transplantation Revealed at World Congress At the World Transplant Congress, new findings from the Bridge to HOPE study highlighted the clinical and economic advantages of the HOPE method in liver transplants, demonstrating reduced rejection rates and costs.

Significant Clinical and Economic Benefits of HOPE in Liver Transplantation Revealed at World Congress #USA #San_Francisco #Bridge_to_Life #Liver_Transplant #Hope

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

New Insights from Bridge to HOPE Clinical Trial Reveal Benefits in Liver Transplantation The recent findings from the Bridge to HOPE clinical trial highlight significant clinical and economic advantages in liver transplantation, reducing costs and complications.

New Insights from Bridge to HOPE Clinical Trial Reveal Benefits in Liver Transplantation #USA #San_Francisco #Bridge_to_Life #Liver_Transplant #HOPE_Trial

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

New Findings Highlight Benefits of Hypothermic Oxygenated Machine Perfusion in Liver Transplants Recent research comparing hypothermic oxygenated machine perfusion (HOPE) and normothermic machine perfusion (NMP) shows superior outcomes for HOPE in liver transplants.

New Findings Highlight Benefits of Hypothermic Oxygenated Machine Perfusion in Liver Transplants #USA #San_Francisco #Bridge_to_Life #Hope #NMP

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

New Study: Hypothermic Oxygenated Perfusion Outperforms Normothermic Machine Perfusion in Liver Transplantation A recent study compares hypothermic oxygenated perfusion (HOPE) with normothermic machine perfusion (NMP) for liver transplants, showing HOPE's superiority in outcomes.

New Study: Hypothermic Oxygenated Perfusion Outperforms Normothermic Machine Perfusion in Liver Transplantation #USA #San_Francisco #VitaSmart #Bridge_to_Life #Hope

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Bridge to Life™ Showcases Innovative HOPE Clinical Data at 2025 Transplant Congress Bridge to Life™ presents groundbreaking 12-month clinical trial findings on HOPE at the World Transplant Congress 2025 in San Francisco.

Bridge to Life™ Showcases Innovative HOPE Clinical Data at 2025 Transplant Congress #USA #San_Francisco #Bridge_to_Life #Hope #transplant_congress

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Bridge to Life™ Reveals Innovative 12-Month Clinical Trial Findings on HOPE at World Transplant Congress 2025 At the World Transplant Congress 2025, Bridge to Life™ Ltd. showcased vital data from its 12-month clinical trial on hypothermic oxygenated perfusion (HOPE), highlighting breakthroughs in liver preservation.

Bridge to Life™ Reveals Innovative 12-Month Clinical Trial Findings on HOPE at World Transplant Congress 2025 #USA #San_Francisco #Bridge_to_Life #organ_preservation #HOPE_Trial

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Bridge to Life™ Unveils Groundbreaking HOPE Trial Data at 2025 World Transplant Congress Bridge to Life™ showcased revolutionary 12-month clinical trial results on HOPE at the World Transplant Congress 2025, emphasizing organ preservation technology.

Bridge to Life™ Unveils Groundbreaking HOPE Trial Data at 2025 World Transplant Congress #USA #San_Francisco #Bridge_to_Life #organ_preservation #Hope

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago